Response Adapted Therapy Using Single Agent Lenalidomide in Older Adults with Newly Diagnosed Standard Risk Multiple Myeloma

被引：0
|
作者：
Baz, Rachid [1 ]
Alsina, Melissa
Shain, Kenneth H. [1 ]
Paleveda, Jennifer [1 ]
Hillgruber, Nancy [1 ]
Finley-Oliver, Elizabeth [1 ]
Ochoa, Leonel
Nishihori, Taiga
Dalton, William [2 ]
Sullivan, Daniel
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL 33612 USA
[2] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Personalized Med Inst, Tampa, FL 33612 USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.4060.4060
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4060
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Exploring Indicators of Vulnerability in Older Adults With Newly Diagnosed Multiple Myeloma
    Wildes, Tanya M.
    JCO CLINICAL CANCER INFORMATICS, 2024, 8
  • [22] Burden of Treatment Among Older Adults With Newly Diagnosed Multiple Myeloma
    Mian, Hira S.
    Fiala, Mark A.
    Wildes, Tanya M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (02): : E152 - E159
  • [23] Substratification of patients with newly diagnosed standard-risk multiple myeloma
    Binder, Moritz
    Rajkumar, S. Vincent
    Ketterling, Rhett P.
    Dispenzieri, Angela
    Lacy, Martha Q.
    Gertz, Morie A.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Hwa, Yi L.
    Zeldenrust, Steven R.
    Lust, John A.
    Russell, Stephen J.
    Leung, Nelson
    Kapoor, Prashant
    Go, Ronald S.
    Gonsalves, Wilson I.
    Kyle, Robert A.
    Kumar, Shaji K.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (02) : 254 - 260
  • [24] Substratification of Patients with Newly Diagnosed Standard-Risk Multiple Myeloma
    Binder, Moritz
    Rajkumar, S. Vincent
    Ketterling, Rhett P.
    Dispenzieri, Angela
    Lacy, Martha Q.
    Gertz, Morie A.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Hwa, Yi L.
    Zeldenrust, Steven R.
    Lust, John A.
    Russell, Stephen J.
    Leung, Nelson
    Kapoor, Prashant
    Go, Ronald S.
    Gonsalves, Wilson I.
    Kyle, Robert A.
    Kumar, Shaji K.
    BLOOD, 2017, 130
  • [25] Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma
    Srivastava, G.
    Rana, V.
    Lacy, M. Q.
    Buadi, F. K.
    Hayman, S. R.
    Dispenzieri, A.
    Gertz, M. A.
    Dingli, D.
    Zeldenrust, S.
    Russell, S.
    McCurdy, A.
    Kapoor, P.
    Kyle, R.
    Rajkumar, S. V.
    Kumar, S.
    LEUKEMIA, 2013, 27 (10) : 2062 - 2066
  • [26] Lenalidomide, Bortezomib, and Dexamethasone (RVD) As Induction Therapy in Newly Diagnosed Multiple Myeloma (MM)
    Joseph, Nisha
    Almaula, Dhwani
    Gleason, Charise
    Heffner, Leonard
    Boise, Lawrence H.
    Kaufman, Jonathan L.
    Lonial, Sagar
    Nooka, Ajay
    BLOOD, 2017, 130
  • [27] The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma
    Maximilian Merz
    Tobias Dechow
    Mithun Scheytt
    Christian Schmidt
    Bjoern Hackanson
    Stefan Knop
    Annals of Hematology, 2020, 99 : 1709 - 1725
  • [28] Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma
    G Srivastava
    V Rana
    M Q Lacy
    F K Buadi
    S R Hayman
    A Dispenzieri
    M A Gertz
    D Dingli
    S Zeldenrust
    S Russell
    A McCurdy
    P Kapoor
    R Kyle
    S V Rajkumar
    S Kumar
    Leukemia, 2013, 27 : 2062 - 2066
  • [29] Decreased neutrophil function in newly diagnosed multiple myeloma patients is restored with lenalidomide therapy
    Askman, Sandra
    Westerlund, Julia
    Pettersson, Asa
    Hellmark, Thomas
    Johansson, Asa
    Wichert, Stina
    Hansson, Markus
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 113 (01) : 72 - 81
  • [30] The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma
    Merz, Maximilian
    Dechow, Tobias
    Scheytt, Mithun
    Schmidt, Christian
    Hackanson, Bjoern
    Knop, Stefan
    ANNALS OF HEMATOLOGY, 2020, 99 (08) : 1709 - 1725
12345